Clinical Trial Update: Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated neoadjuvant docetaxel, cisplatin, and 5-fluorouracil followed by chemoradiotherapy versus chemoradiotherapy alone in locally advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Head and Neck Neoplasms | Phase 2 | Status: COMPLETED